Resolving hot spots in the C-terminal dimerization domain that determine the stability of the molecular chaperone
Emanuele Ciglia1, Janina Vergin2, Sven Reimann3
1Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University, Düsseldorf, Germany.
Abstract:
Human heat shock protein of 90 kDa (hHsp90) is a homodimer that has an essential role in facilitating malignant transformation at the molecular level. Inhibiting hHsp90 function is a validated approach for treating different types of tumors. Inhibiting the dimerization of hHsp90 via its C-terminal domain (CTD) should provide a novel way to therapeutically interfere with hHsp90 function. Here, we predicted hot spot residues that cluster in the CTD dimerization interface by a structural decomposition of the effective energy of binding computed by the MM-GBSA approach and confirmed these predictions using in silico alanine scanning with DrugScore(PPI). Mutation of these residues to alanine caused a significant decrease in the melting temperature according to differential scanning fluorimetry experiments, indicating a reduced stability of the mutant hHsp90 complexes. Size exclusion chromatography and multi-angle light scattering studies demonstrate that the reduced stability of the mutant hHsp90 correlates with a lower complex stoichiometry due to the disruption of the dimerization interface. These results suggest that the identified hot spot residues can be used as a pharmacophoric template for identifying and designing small-molecule inhibitors of hHsp90 dimerization.
Insights
Identifying key residues in human heat shock protein 90 kDa (hHsp90) C-terminal domain is crucial for developing novel cancer therapies. Disrupting hHsp90 dimerization offers a promising strategy to inhibit malignant transformation.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Human heat shock protein 90 kDa (hHsp90) is a molecular chaperone essential for malignant transformation.
- Inhibiting hHsp90 function is a validated strategy for cancer treatment.
- Targeting hHsp90 dimerization presents a novel therapeutic approach.
Purpose of the Study:
- To identify critical residues in the hHsp90 C-terminal domain (CTD) involved in dimerization.
- To validate these residues as potential targets for small-molecule inhibitors.
Main Methods:
- Computational methods: MM-GBSA and in silico alanine scanning (DrugScorePPI) to predict hot spot residues.
- Experimental validation: Differential scanning fluorimetry, size exclusion chromatography, and multi-angle light scattering.
Main Results:
- Predicted hot spot residues in the hHsp90 CTD dimerization interface were identified.
- Mutating these residues significantly decreased complex stability and disrupted dimerization.
- Reduced stability correlated with lower complex stoichiometry, confirming the disruption of the dimerization interface.
Conclusions:
- The identified hot spot residues serve as a pharmacophoric template for designing hHsp90 dimerization inhibitors.
- Targeting hHsp90 dimerization offers a promising strategy for cancer therapy.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
Bacterial Protein Maturation
Protein Folding
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...


